LSL Pharma Group Inc.
LSL.V
TSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -- | -45.55% | -- | -- | -- |
Total Receivables | 93.54% | 116.47% | -- | 164.53% | -12.98% |
Inventory | 45.59% | 16.54% | -- | 42.41% | 12.49% |
Prepaid Expenses | 71.02% | 149.16% | -- | 100.59% | 38.51% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 63.99% | 41.06% | -- | 67.99% | 3.40% |
|
|||||
Total Current Assets | 63.99% | 41.06% | -- | 67.99% | 3.40% |
Net Property, Plant & Equipment | 27.34% | 24.55% | -- | 8.59% | 8.09% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 4.90% | -0.22% | -- | 1.91% | -2.55% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -3.31% | -- | 2.03% | 1.37% |
Total Assets | 28.17% | 20.94% | -- | 15.95% | 3.80% |
|
|||||
Total Accounts Payable | -14.41% | -37.66% | -- | 11.09% | -39.06% |
Total Accrued Expenses | -- | -- | -- | -31.38% | -- |
Short-term Debt | -60.64% | 55.86% | -- | 32.54% | 172.28% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -35.68% | 160.15% | -- | 218.62% | 297.17% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 60.50% |
Total Other Current Liabilities | -- | -- | -- | -- | 60.50% |
Total Current Liabilities | -40.47% | -13.91% | -- | 32.97% | 40.23% |
|
|||||
Total Current Liabilities | -40.47% | -13.91% | -- | 32.97% | 40.23% |
Long-Term Debt | 104.14% | -7.82% | -- | -38.15% | -56.46% |
Short-term Debt | -60.64% | 55.86% | -- | 32.54% | 172.28% |
Capital Leases | 4.26% | -8.64% | -- | -2.44% | -3.44% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -11.51% | -11.06% | -- | 3.53% | -0.75% |
|
|||||
Common Stock & APIC | 43.45% | 33.94% | -- | 80.51% | 81.44% |
Retained Earnings | -9.48% | -8.33% | -- | -91.42% | -167.20% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 109.16% | 78.66% | 176.94% | 67.64% | 14.51% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 109.16% | 78.66% | 176.94% | 67.64% | 14.51% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 109.16% | 78.66% | 176.94% | 67.64% | 14.51% |
|